ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "What’s new in primary ITP? Key updates from ASH 2024"
Episode Synopsis
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#
In God we trust